Cronos Group Inc. ($CRON) Stock Forecast: Up 5.2% Today

What is Cronos Group Inc.?

Cronos Group Inc. (CRON) is a cannabis company listed on the NASDAQ stock exchange. The stock has been showing bullish movement recently despite the overall market trend.

Why is Cronos Group Inc. going up?

CRON stock is up 5.2% on Mar 25, 2026 14:10

• Cronos Group Inc. (CRON) has been experiencing consecutive days of stock price increases, outperforming the broader market.
• Positive news such as beating EPS and revenue expectations in recent earnings reports and legislative efforts to protect legal cannabis businesses in the U.S. have likely contributed to the bullish momentum.
• Insider trading activity, with an officer exercising restricted stock units and increasing their direct holdings, may also signal confidence in the company's future prospects.
• The overall positive sentiment towards the cannabis sector and specific company developments seem to be driving the bullish movement in CRON stock despite its unprofitable status and negative margins.

CRON Price Chart

CRON Technical Analysis

CRON News

Cronos Group Inc. stock rises Tuesday, outperforms market

Cronos Group Inc. (CRON) saw its stock rise by 2.38% on Tuesday, closing at $2.58. This gain occurred during a generally down market, where the NASDAQ Composite Index fell by 0.84% and the Dow Jones Industrial Average dropped by 0.18%. This marks the second consecutive day of gains for Cronos Group Inc.

https://www.marketwatch.com/data-news/cronos-group-inc-stock-rises-tuesday-outperforms-market-7a9c2dcb-f95391fac639?gaa_at=eafs&gaa_n=AWEtsqcVse8MSw864vx3cTzQ0eIZymI3P4H07JYnuy5006htpZNjMB56cFTv&gaa_ts=69c378b2&gaa_sig=FU_NO_XPKCFVuLv1Vip2p2iAN9vmteSOR2_KDp9Vl134cYisAjgzjC7WPAE-WN4LSxpQdri6V5leZyZOlXnKNg%3D%3D

Cronos Group Inc. stock rises Monday, outperforms market

Shares of Cronos Group Inc. (CRON) rose 5.44% to $2.52 on Monday, outperforming the broader market. This increase ended a three-day losing streak for the stock, while the NASDAQ Composite Index and Dow Jones Industrial Average also saw significant gains.

https://www.marketwatch.com/data-news/cronos-group-inc-stock-rises-monday-outperforms-market-e4f8b868-29f67c73f0e7?gaa_at=eafs&gaa_n=AWEtsqd8J_NgYBpMfoSgIBRxv8J17ep3F3SmHiSiUjJpa4VmFqY9ls_HaECW&gaa_ts=69c2cfb3&gaa_sig=N1NF2fwNX79MDn7T0gLU8SFAr2hwyaW1TvMfb9xlkHUvjM4H1X9OD6VQddbDsyoAts2TeIOvs6FWQFetNRmvzQ%3D%3D

Cronos Group Inc. (NASDAQ:CRON) Receives Average Recommendation of "Hold" from Analysts

Cronos Group Inc. (NASDAQ:CRON) has an average "Hold" recommendation from analysts, with a 1-year average price target of $2.30. Despite beating EPS and revenue expectations in its last earnings report, the company remains unprofitable with negative margins. Institutional investors have significantly increased their stakes in CRON, yet the stock opened at $2.39, below its moving averages.

https://www.marketbeat.com/instant-alerts/cronos-group-inc-nasdaqcron-receives-average-recommendation-of-hold-from-analysts-2026-03-21/

CRON Stock News Today | Earnings, Events & Price Alerts

This article provides recent news and events related to Cronos Group (CRON), a cannabis company. Key updates include recent Q4 2025 earnings reports showing record revenue and a Q4 revenue beat despite a net loss, as well as legislative efforts to protect legal cannabis businesses in the U.S. The article also highlights significant increases in borrow rates for CRON stock among liquid option names.

https://intellectia.ai/en/stock/CRON/news

[Form 4] Cronos Group Inc. Insider Trading Activity

Cronos Group Inc. officer Anna Shlimak exercised restricted stock units (RSUs) on March 19, 2026, converting 28,429 units into common shares as the first vesting portion of an 85,297-unit grant from March 2025. To cover tax obligations, 9,767 shares were withheld and disposed of at $2.54 per share. Following these transactions, Shlimak directly holds 358,595 common shares.

https://www.stocktitan.net/sec-filings/CRON/form-4-cronos-group-inc-insider-trading-activity-9173acb25732.html

Trending Today

Meta Platforms, Inc. ($META) Stock Forecast: Down 5.1% Today

Citigroup Inc. ($C) Stock Forecast: Down 4.8% Today

Moderna Inc. ($MRNA) Stock Forecast: Down 5.2% Today

Motorola Solutions Inc. ($MSI) Stock Forecast: Down 4.0% Today

TripAdvisor Inc. ($TRIP) Stock Forecast: Up 5.2% Today

TKO Group Holdings Inc ($TKO) Stock Forecast: Down 4.7% Today

FuelCell Energy ($FCEL) Stock Forecast: Down 5.3% Today

Teladoc Health Inc. ($TDOC) Stock Forecast: Down 5.3% Today

Upwork Inc. ($UPWK) Stock Forecast: Down 5.3% Today

Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Down 6.9% Today

Cronos Group Inc. Price History

29.00.2026 - CRON Stock was down 7.0%

• Analysts at Canaccord Genuity Group issued a "buy" rating with a target price of C$4.25, indicating a possible upside. The general analyst consensus, however, continues to suggest a "Hold," with the average price target at $2.30.
• Although the company boasts a solid financial position with no debts and substantial cash reserves amounting to $824 million, concerns over a negative EPS forecast for the current fiscal year might have influenced the recent market decline.
• The company's strong operational performance and revenue growth in Q3 2025, largely propelled by the success of the Spinach brand and expansion initiatives, were somewhat overshadowed by uncertainties surrounding future profitability.
• The discussion of alternative AI stocks offering greater potential for market growth could have diverted investor focus from Cronos Group, contributing to its recent stock performance downturn.

19.11.2025 - CRON Stock was down 6.8%

• The bearish movement in CRON today could be attributed to profit-taking by investors after a series of significant stock price surges in response to the company's European expansion efforts.
• Despite the positive news of Cronos Group's strategic acquisition of CanAdelaar and its expansion into Europe, investors may be reevaluating the stock's valuation, which has been considered overvalued by some analysts.
• The high valuation and potential risks associated with delays or policy reversals in the cannabis sector may have contributed to the bearish sentiment towards CRON today.
• While the company's moves to capitalize on the evolving cannabis markets are promising, investors may be exercising caution amidst concerns about sustainability and profitability in the long term.

15.11.2025 - CRON Stock was down 5.0%

• Despite recent positive developments in Cronos Group's expansion into Europe and the surge in its stock price, today's bearish movement could be attributed to profit-taking by investors after a period of strong gains.
• Concerns about overvaluation and potential risks such as policy reversals or revenue growth delays might have contributed to the downward pressure on CRON's stock.
• Investors may be reevaluating their positions in CRON, considering the mixed financial metrics and the company's premium valuation compared to industry peers.
• While Cronos Group's strategic acquisitions and market expansions have generated positive feedback, market participants are likely being cautious amidst uncertainties in the cannabis sector and broader market conditions.

09.11.2025 - CRON Stock was up 6.4%

• The bullish movement in CRON stock today could be attributed to the strategic partnership announced between Crypto.com and 21shares to expand access to the Cronos ecosystem. This partnership is likely seen as a positive development for Cronos Group, potentially boosting investor confidence in the company's future prospects.
• Despite the slight dip in CRON shares recently, the overall market sentiment seems to have been positively influenced by the news of the strategic partnership. Investors may be focusing more on the long-term growth potential of Cronos Group rather than short-term fluctuations in share price.
• The announcement of new investment products tracking the Cronos token could have also contributed to the bullish movement, as it indicates increasing interest and adoption of Cronos' ecosystem, potentially driving up demand for the company's products and services.

22.11.2025 - CRON Stock was down 5.1%

• The stock fell on Wednesday, underperforming the overall market, which could be attributed to profit-taking or market correction.
• Despite being considered a safer bet in the cannabis industry due to its strong financial position and disciplined management, the high valuation and limited direct benefits from potential US cannabis rescheduling might have dampened investor enthusiasm.
• The company's improved gross margins and profitability could be overshadowed by the broader market sentiment or sector-specific challenges, leading to the bearish movement in the stock today.
• Investors may be reevaluating their positions in CRON amidst uncertainties surrounding cannabis regulations and market dynamics, contributing to the downward pressure on the stock price.

12.00.2026 - CRON Stock was up 2.6%

• Cronos' bullish movement was driven by its recent announcement of expanding into the Netherlands through the acquisition of Europe’s largest adult-use cannabis company. This strategic move is expected to unlock new revenue streams and enhance Cronos' position in the global cannabis market.
• Furthermore, positive trading plans and investment analysis on CRON:CA may have also influenced the stock's upward momentum. Analysts and AI-generated ratings suggesting buying at specific price levels and implementing stop-loss measures could have instilled confidence in investors.
• In conclusion, Cronos' strategic expansion initiatives, along with favorable trading recommendations and investment analysis, have instilled optimism among investors, triggering the significant bullish movement observed in the stock today.

03.01.2026 - CRON Stock was up 5.1%

• The bullish movement in CRON today can be attributed to the launch of its premium cannabis brand, Lord Jones®, in Israel. This strategic expansion into new markets with high-quality products showcases the company's commitment to growth and innovation.
• Additionally, the bullish thesis surrounding potential regulatory changes in the US, specifically the reclassification of marijuana as a Schedule III substance, has likely fueled investor optimism. This shift could lead to improved financial performance for CRON by reducing tax burdens and enhancing operational efficiency.
• Despite recent declines and cautious Wall Street analyst ratings, CRON's forward-thinking approach to product strategy and potential regulatory tailwinds seem to have resonated positively with investors, driving the stock's bullish momentum today.

29.08.2025 - CRON Stock was up 3.7%

• CRON experienced a strong bullish movement despite recent losses in market cap, showcasing resilience in the face of market challenges.
• The surge in CRON's stock price could be attributed to positive earnings reports or potential partnerships that have sparked investor optimism.
• Despite the recent setbacks and market fluctuations, CRON's bullish movement indicates that investors still see long-term potential in the company's growth prospects.
• The community's questioning of demand for Cronos products may have been overshadowed by positive developments within the company, leading to the bullish market movement.

29.08.2025 - CRON Stock was up 2.3%

• President Trump's support for CBD on Truth Social led to a surge in cannabis stock prices, including CRON.
• Despite the initial increase, CRON experienced a drop in market cap erasing the gains following Trump's post.
• There are concerns in the community regarding the demand for CRON after the market rally, indicating a possible shift in sentiment.
• The fluctuating movements in CRON following Trump's post highlight the unpredictable nature of cannabis stocks in response to political and regulatory developments.

25.02.2026 - CRON Stock was up 5.2%

• Cronos Group Inc. (CRON) has been experiencing consecutive days of stock price increases, outperforming the broader market.
• Positive news such as beating EPS and revenue expectations in recent earnings reports and legislative efforts to protect legal cannabis businesses in the U.S. have likely contributed to the bullish momentum.
• Insider trading activity, with an officer exercising restricted stock units and increasing their direct holdings, may also signal confidence in the company's future prospects.
• The overall positive sentiment towards the cannabis sector and specific company developments seem to be driving the bullish movement in CRON stock despite its unprofitable status and negative margins.

12.11.2025 - CRON Stock was up 8.2%

• CRON stock surged by 7.56% after acquiring CanAdelaar, Europe's largest adult-use cannabis company. This acquisition provides Cronos Group with a strong presence in the growing European market, leading to increased investor optimism.
• The company's strategic move into Europe's medical cannabis market and the acquisition of CanAdelaar are viewed as positive growth opportunities, driving up the stock price.
• Investors are analyzing the potential impact of this expansion on Cronos Group's market share and premium products, which have contributed to the bullish market movement.
• Despite regulatory risks in Europe, Cronos Group's CEO highlighted the financial and strategic significance of the expansion, boosting investor confidence in the company's future prospects.

10.11.2025 - CRON Stock was up 6.3%

• The positive market sentiment surrounding CRON stock is linked to its acquisition of CanAdelaar B.V., which expands Cronos Group's reach in the European adult-use cannabis market.
• Entering the European market is viewed as a strategic move to enhance Cronos's product development capabilities and global cannabinoid presence, attracting investor interest.
• The partnership with Crypto.com and 21shares is enhancing access to the Cronos ecosystem and creating new investment opportunities, contributing to the bullish momentum.
• Despite challenges like negative net margins and return on equity, Cronos Group's expansion efforts and strategic acquisitions have boosted investor confidence, reflected in the upward movement of its stock price.